Preventing, Treating Relapse After ASCT in Hematologic Malignancy Patients
This video highlights research into the use of post-transplant therapies to prevent or treat disease recurrence following allogeneic stem cell transplantation.
In this video, Robert J. Soiffer, MD, of the Dana-Farber Cancer Institute in Boston, highlights research into the use of post-transplant therapies to prevent or treat disease recurrence following allogeneic stem cell transplantation (ASCT).
Soiffer gave a presentation on this topic during an education session at the 2017 American Society of Hematology (ASH) Annual Meeting and Exposition, held December 9–12 in Atlanta.
Oncology Peer Review On-The-Go: Minority Treatment Disparities and Clinical Trial Enrollment
July 6th 2020The first episode of CancerNetwork's podcast Oncology Peer Review On-The-Go explores disparities in cancer care treatment among minorities and the significance of a representative sample in clinical trials.
